TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35608666

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 70
Study: 34228735

Group type: EXPERIMENTAL
Intervention: QUiPP app with admission, antenatal corticosteroids (ACSs), and transfer advised for women with a QUiPP risk of delivery >5% within 7 days.
Number of subjects: 1872

Group type: EXPERIMENTAL
Intervention: QUiPP app
Number of subjects: 1872

Group type: COMPARATOR
Intervention: Conventional management of TPTL at control sites.
Number of subjects: 1872

Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 1872
Study: 35083027

Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention
Number of subjects: 99

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 99
Study: 33749976

Group type: EXPERIMENTAL
Intervention: Adherence to biological metrics of Life's Simple 7 (LS7)
Number of subjects: 229976

Group type: EXPERIMENTAL
Intervention: Genetically elevated blood pressure
Number of subjects: 229976
Study: 32191198

Group type: EXPERIMENTAL
Intervention: Point-of-care testing (POCT)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Central laboratory testing (CLT)
Number of subjects: 248
Study: 36162898

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS) system
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study: 32842769

Group type: EXPERIMENTAL
Intervention: HoLEP (Versa pulse® 100 W; n=73)
Number of subjects: 145

Group type: COMPARATOR
Intervention: BPRP (AUTOCON® II 400 ESU; n=72)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Both HoLEP and BPRP
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: HoLEP
Number of subjects: 145
Study: 34693583

Group type: EXPERIMENTAL
Intervention: Remote monitoring and feedback using a smartphone application
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unmonitored period (control)
Number of subjects: 40
Study: 32221084

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine combined with western medicine (ESWL treatment and TCM therapy)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional drug treatment (control group)
Number of subjects: 100
Study: 36134468

Group type: EXPERIMENTAL
Intervention: Closed Facebook group for PPIE
Number of subjects: 289
Study: 33760428

Group type: EXPERIMENTAL
Intervention: Behavioral health reentry intervention (details not specified)
Number of subjects: 327
Study: 32803900

Group type: EXPERIMENTAL
Intervention: Once-weekly exenatide (EQW)
Number of subjects: 3503

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3503
Study: 34985309

Group type: COMPARATOR
Intervention: Standard-dose DOAC
Number of subjects: 71683

Group type: COMPARATOR
Intervention: Lower-dose DOAC
Number of subjects: 71683
Study: 32891639

Group type: EXPERIMENTAL
Intervention: Pathway group (NEEW + enhanced recovery after surgery)
Number of subjects: 192
Study: 33322340

Group type: EXPERIMENTAL
Intervention: Low Protein Diet (LPD) - 5% protein
Number of subjects: 23
Study: 35507322

Group type: EXPERIMENTAL
Intervention: PrEP (Pre-exposure prophylaxis)
Number of subjects: 33
Study: 33528930

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy with allergens (SCITA)
Number of subjects: 46
Study: 36342119

Group type: EXPERIMENTAL
Intervention: Device-based temperature control targeting 36°C for 24 hours followed by targeting of 37°C for 12 hours (total 36 hours)
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: Device-based temperature control targeting 36°C for 24 hours followed by targeting of 37°C for 48 hours (total 72 hours)
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: Device-based temperature control for 36 hours
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: Device-based temperature control for 72 hours
Number of subjects: 789
Study: 34192298

Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia and epidural analgesia
Number of subjects: 400

Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 400
Study: 35033600

Group type: EXPERIMENTAL
Intervention: Fusion radiomic model
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Clinicoradiomic model
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Radiomic model and clinicoradiomic model
Number of subjects: 134
Study: 32734732

Group type: EXPERIMENTAL
Intervention: Active air purifiers with HEPA filters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo air purifiers
Number of subjects: 0
Study: 32097166

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting SPLD risk
Number of subjects: 2071

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 2071

Group type: COMPARATOR
Intervention: Nomogram compared to Child-Pugh, MELD, ALBI, and EASL algorithm
Number of subjects: 2071
Study: 33237618

Group type: EXPERIMENTAL
Intervention: Hypothermic Oxygenated Perfusion (HOPE)
Number of subjects: 25
Study: 36114466

Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided erector spinae plane (ESP) block
Number of subjects: 47

Group type: COMPARATOR
Intervention: Superficial parasternal intercostal plane (S-PIP) plus ESP block
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study: 34304268

Group type: EXPERIMENTAL
Intervention: MoveMore intervention plus usual care (UC)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Usual care (UC) only
Number of subjects: 153
Study: 32118304

Group type: EXPERIMENTAL
Intervention: Surgically managed (SX)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Nonsurgically managed (non-SX)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Unexposed horses
Number of subjects: 98
Study: 35428653

Group type: EXPERIMENTAL
Intervention: 30 Gy in 10 fractions over two weeks (arm A)
Number of subjects: 95

Group type: COMPARATOR
Intervention: 20 Gy in 5 fractions over one week (arm B)
Number of subjects: 95
Study: 33481449

Group type: EXPERIMENTAL
Intervention: HU-014
Number of subjects: 267

Group type: COMPARATOR
Intervention: Onabotulinumtoxin A
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: HU-014 and Onabotulinumtoxin A
Number of subjects: 267
Study: 33778830

Group type: EXPERIMENTAL
Intervention: Extraction site preservation (experimental group)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Routine tooth extraction (control group)
Number of subjects: 85
Study: 36288428

Group type: EXPERIMENTAL
Intervention: Active air cleaner
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 85
Study: 34423994

Group type: EXPERIMENTAL
Intervention: Distance learning context
Number of subjects: 60

Group type: COMPARATOR
Intervention: In-person classroom context
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fear of COVID-19
Number of subjects: 60
Study: 32894145

Group type: EXPERIMENTAL
Intervention: Birth plan implementation training session at weeks 32-36 of gestation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 106
Study: 35435087

Group type: EXPERIMENTAL
Intervention: Plasma gel
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Plasma fluid
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (Plasma gel vs Plasma fluid)
Number of subjects: 27
Study: 33900137

Group type: EXPERIMENTAL
Intervention: Decompressive surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32758407

Group type: EXPERIMENTAL
Intervention: Sternotomy group (15 patients) received 0.25% bupivacaine subcutaneous infiltration.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thoracotomy group (15 patients) with 11 receiving fascial plane block and 3 receiving subcutaneous infiltration.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thoracotomy group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 34731062

Group type: EXPERIMENTAL
Intervention: Supportive counseling (individual sessions and telephone consultation)
Number of subjects: 166
Study: 35545982

Group type: EXPERIMENTAL
Intervention: Listening to 440Hz music
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Listening to 432Hz music
Number of subjects: 54

Group type: COMPARATOR
Intervention: Liberal activity (control group)
Number of subjects: 54
Study: 35399551

Group type: EXPERIMENTAL
Intervention: Web-based diet and PA promotion intervention based on self-determination theory and motivational interviewing
Number of subjects: 1142
Study: 33625064

Group type: EXPERIMENTAL
Intervention: Dolutegravir with emtricitabine plus tenofovir alafenamide (TAF)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Dolutegravir with emtricitabine plus tenofovir disoproxil fumarate (TDF)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 314
Study: 33049433

Group type: EXPERIMENTAL
Intervention: Statistical prediction
Number of subjects: 151

Group type: COMPARATOR
Intervention: Clinical judgment (recommended treatment)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Cognitive therapy (CT)
Number of subjects: 151
Study: 32005104

Group type: EXPERIMENTAL
Intervention: Kuchi-kara Taberu index (KT index) used in the intervention group
Number of subjects: 112

Group type: COMPARATOR
Intervention: MDCC program (control group)
Number of subjects: 112
Study: 32866480

Group type: EXPERIMENTAL
Intervention: Endoscopic balloon dilation
Number of subjects: 150

Group type: COMPARATOR
Intervention: No dilation (control group)
Number of subjects: 150
Study: 35253709

Group type: EXPERIMENTAL
Intervention: Rest combined with correct posture, eye rest and self-stretching
Number of subjects: 44

Group type: COMPARATOR
Intervention: Rest only (Control)
Number of subjects: 44
Study: 33802913

Group type: EXPERIMENTAL
Intervention: Blended CBT
Number of subjects: 129

Group type: COMPARATOR
Intervention: Face-to-face CBT
Number of subjects: 129

Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 129
Study: 34524145

Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 1023
Study: 33243160

Group type: EXPERIMENTAL
Intervention: RS‐2 & usual care
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: RS‐2 & aerobic exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (cornstarch) & usual care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo & exercise
Number of subjects: 60
Study: 35311687

Group type: EXPERIMENTAL
Intervention: blended cognitive behavioral therapy (bCBT)
Number of subjects: 943

Group type: COMPARATOR
Intervention: treatment-as-usual (TAU)
Number of subjects: 943
Study: 32130302

Group type: EXPERIMENTAL
Intervention: H. pylori positive individuals
Number of subjects: 63

Group type: COMPARATOR
Intervention: Functional dyspeptic patients (cases)
Number of subjects: 63
Study: 35536715

Group type: EXPERIMENTAL
Intervention: Healthy Homes/Healthy Families intervention
Number of subjects: 114
Study: 34230002

Group type: EXPERIMENTAL
Intervention: Endoluminal radiofrequency ablation prior to metal stent insertion
Number of subjects: 76

Group type: COMPARATOR
Intervention: Self-expandable metal stent insertion
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Endoluminal radiofrequency ablation prior to metal stent insertion (cholangiocarcinoma subgroup)
Number of subjects: 76
Study: 36194256

Group type: EXPERIMENTAL
Intervention: Intact umbilical cord milking (UCM)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 73
Study: 33191157

Group type: EXPERIMENTAL
Intervention: Medication reconciliation by a pharmacy team
Number of subjects: 221

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 221
Study: 35611515

Group type: EXPERIMENTAL
Intervention: Manual acupressure
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Wristband acupressure
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo manual acupressure
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo wristband acupressure
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Additional antiemetic drug use
Number of subjects: 44
Study: 33023788

Group type: EXPERIMENTAL
Intervention: Let's Choose Ourselves with distractions in the simulator protocol at baseline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Let's Choose Ourselves with no distractions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Attention control intervention on healthy eating with distractions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Attention control with no distractions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Self-reported risky driving behaviors
Number of subjects: 60
Study: 33110039

Group type: EXPERIMENTAL
Intervention: E2/P4 1/100 mg/mg
Number of subjects: 726

Group type: EXPERIMENTAL
Intervention: E2/P4 0.5/100 mg/mg
Number of subjects: 726

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study: 33215755

Group type: EXPERIMENTAL
Intervention: Immediately loaded implants with a provisional fixed prosthesis
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventionally loaded implants
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups (immediate and conventional loading)
Number of subjects: 26
Study: 32061974

Group type: EXPERIMENTAL
Intervention: Isolated MPFL sectioning
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Complete proximal medial patellar restraint (PMPR) sectioning
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Complete sectioning following isolated MPFL sectioning
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intact state
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lateral retinacular release
Number of subjects: 12
Study: 35642464

Group type: EXPERIMENTAL
Intervention: Early computed tomography coronary angiography (CTCA)
Number of subjects: 1748

Group type: EXPERIMENTAL
Intervention: Cardiac troponin elevation
Number of subjects: 1748

Group type: EXPERIMENTAL
Intervention: Presentation cardiac troponin
Number of subjects: 1748
Study: 33065462

Group type: EXPERIMENTAL
Intervention: pSUVmax < 14.4
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: pSUVmax 14.4−17.5
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: pSUVmax > 17.5
Number of subjects: 133
Study: 34144359

Group type: EXPERIMENTAL
Intervention: Air-abrasion with 110 µm Al2O3 particles (AlOx)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No surface treatment (CTRL)
Number of subjects: 30
Study: 32232495

Group type: EXPERIMENTAL
Intervention: Standardized patient-based training
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Standardized patient-based training (after crossover)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 20
Study: 35150243

Group type: COMPARATOR
Intervention: Healthy non-depressed adults
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Patients with major depressive disorder
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Modafinil 100 mg
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Dopamine D2/D3 receptor availability
Number of subjects: 54
Study: 33326648

Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 32611448

Group type: EXPERIMENTAL
Intervention: Esophagectomy
Number of subjects: 176

Group type: COMPARATOR
Intervention: Definitive chemoradiotherapy (dCRT)
Number of subjects: 176
Study: 34965642

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Asthma group (ICS and montelukast combined)
Number of subjects: 155
Study: 32403066

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 0
Study: 616781134

Group type: EXPERIMENTAL
Intervention: 9-month physical activity intervention
Number of subjects: 154

Group type: COMPARATOR
Intervention: Waitlist-control condition
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 9-month physical activity intervention (among obese participants)
Number of subjects: 154
Study: 36457044

Group type: EXPERIMENTAL
Intervention: InTSHA (Interactive Transition Support for Adolescents Living with HIV) - a multi-module, moderated WhatsApp-based intervention
Number of subjects: 21
Study: 32308037

Group type: EXPERIMENTAL
Intervention: Message designed to convey source expertise
Number of subjects: 1000
Study: 33590270

Group type: EXPERIMENTAL
Intervention: Singing intervention
Number of subjects: 35
Study: 32452818

Group type: EXPERIMENTAL
Intervention: Mobile phone-delivered just-in-time planning intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: Assessment only (control)
Number of subjects: 136
Study: 36017827

Group type: EXPERIMENTAL
Intervention: Multi-day rivastigmine transdermal patch (RID-TDS), applied on a 4-3-4 day regimen for 11 consecutive days.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Exelon® transdermal patch, applied daily for 11 consecutive days.
Number of subjects: 57
Study: 34147462

Group type: EXPERIMENTAL
Intervention: Peer-group-based intervention (IG)
Number of subjects: 543

Group type: COMPARATOR
Intervention: Self-management control group (CG)
Number of subjects: 543
Study: 36106868

Group type: EXPERIMENTAL
Intervention: Complete Mesocolic Excision (CME)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Non-Complete Mesocolic Excision (NCME)
Number of subjects: 390
Study: 32682361

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy (US)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 40
Study: 36155117

Group type: EXPERIMENTAL
Intervention: Palbociclib plus letrozole
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 340
Study: 33158772

Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Number of subjects: 372

Group type: COMPARATOR
Intervention: Vorinostat
Number of subjects: 372
Study: 35351835

Group type: EXPERIMENTAL
Intervention: Capsaicin perfusion
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline perfusion
Number of subjects: 13
Study: 34758251

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase followed by EVT
Number of subjects: 539

Group type: COMPARATOR
Intervention: EVT alone
Number of subjects: 539
Study: 32320401

Group type: EXPERIMENTAL
Intervention: Febuxostat (10-60 mg daily)
Number of subjects: 483

Group type: COMPARATOR
Intervention: Control (non-pharmacological lifestyle modification)
Number of subjects: 483
Study: 35357763

Group type: EXPERIMENTAL
Intervention: 595-nm pulsed dye laser
Number of subjects: 90

Group type: COMPARATOR
Intervention: Microwave tissue coagulation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Liquid nitrogen cryotherapy
Number of subjects: 90
Study: 32546192

Group type: EXPERIMENTAL
Intervention: Primary outcome data
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Non-outcome data
Number of subjects: 18
Study: 33433071

Group type: EXPERIMENTAL
Intervention: Suture-fixation mucopexy (SF), N=60
Number of subjects: 123

Group type: COMPARATOR
Intervention: Milligan-Morgan hemorrhoidectomy (MM), N=63
Number of subjects: 123
Study: 33179359

Group type: EXPERIMENTAL
Intervention: Soft contact lens wear
Number of subjects: 963
Study: 34821978

Group type: EXPERIMENTAL
Intervention: Fluoride varnish
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Pastes containing CPP-ACP
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Pastes containing CPP-ACFP
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (oral hygiene motivation only)
Number of subjects: 67
Study: 35230051

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32147225

Group type: EXPERIMENTAL
Intervention: 900 μg salbutamol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (healthy age- and gender-matched)
Number of subjects: 30
Study: 32757777

Group type: EXPERIMENTAL
Intervention: Local corticosteroid injections
Number of subjects: 163

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 163
Study: 33973551

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy (three cycles of full-dose anthracycline and ifosfamide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nomograms for risk prediction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perioperative systemic treatment
Number of subjects: 0
Study: 35275606

Group type: EXPERIMENTAL
Intervention: In-clinic visit model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In-person group sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phone group sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diabetes patients on insulin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diabetes patients not on insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diabetes group
Number of subjects: 0
Study: 32945993

Group type: EXPERIMENTAL
Intervention: Rare gene variants in women with severe OHSS (grades 4 and 5)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pathway analysis of OHSS variant lists
Number of subjects: 12

Group type: COMPARATOR
Intervention: Matched controls developing no signs of OHSS (Golan grade 0)
Number of subjects: 12
Study: 35627382

Group type: EXPERIMENTAL
Intervention: In-person counseling (PE)
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: Computer-based BAI (CO)
Number of subjects: 961

Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 961
Study: 34271366

Group type: EXPERIMENTAL
Intervention: Calcium intake
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Vitamin D intake
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Vitamin D status at 13 weeks’ gestation
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Vitamin D status at 28 weeks’ gestation
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Vitamin D status at 5-year follow-up
Number of subjects: 415
Study: 34357396

Group type: EXPERIMENTAL
Intervention: 2-hour infusion of Vasoactive Intestinal Polypeptide (VIP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21